ROR-107

N/A

Report date: 2025/01/26 16:30:38
NME

Base Information

Drug NameROR-107
Drug Alias Namedual GPBAR1 agonist/RORgammaT inverse agonist (Precision Bio-Therapeutics/Universita degli Studi di Napoli Federico II/Universita degli Studi di Perugia/Azienda Ospedaliera di Perugia, Perugia)ROR-107
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear receptor ROR-gamma inverse agonistsG-protein coupled bile acid receptor 1 agonists
TargetsG-protein coupled bile acid receptor 1Nuclear receptor ROR-gamma
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversità Degli Studi Di Perugia
China Registration ClassN/A

Develop Information

Active CompaniesPrecision Bio-Therapeutics SrlUniversity of Naples Federico IIUniversità Degli Studi Di Perugia +[4] 
Inactive CompaniesN/A
Active IndicationsInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A